Evidence map›Paper›PMID 36879697›Full record

ArticleCureus2023

Cerebral Sinus Thrombosis and Immune Thrombocytopenia Post COVID-19 Vaccination: A Case Report and Narrative Review.

Azka Ali, Arthur Dilibe, Shilpa Rai, Ayoola Awosika, Adekunle E Omole, Maryam Ahmed, Stella Nwosu

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 3 countries.

Azka AliInternal Medicine, Rosalind Franklin University of Medicine and Sciences, Chicago, USA.
Arthur DilibeInternal Medicine, East Carolina University Health, Greenville, USA.
Shilpa RaiInternal Medicine, Isra University, Hyderabad, PAK.
Ayoola AwosikaCollege of Medicine, University of Illinois, Chicago, USA.
Adekunle E OmoleAnatomical Sciences, American University of Antigua, College of Medicine, Saint John, ATG.
Maryam AhmedInternal Medicine, Allied Hospital, Maple Heights, USA.
Stella NwosuHematology and Medical Oncology, Emory University, Atlanta, USA.
Emory University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vaccine-induced immune thrombocytopenia and thrombosis (VITT) following the adenoviral vector COVID-19 vaccine is a rare adverse event. Although the risk of VITT following the COVID-19 vaccine appears to be low, early diagnosis and management can be lifesaving. We present a case of VITT in a young female who presented with persistent headaches and fevers followed by anisocoria and right-sided hemiplegia. Initial imaging was unremarkable, and labs showed thrombocytopenia and elevated d-dimers. Repeat imaging revealed thrombosis in the left transverse and superior sagittal sinuses, and she was diagnosed with VITT. She received combined treatment with intravenous immunoglobulins and systemic anticoagulation, resulting in an increased platelet count and resolution of her neurological symptoms.

Indexed as

2019 novel coronaviruspost-covid 19 vaccine complicationsthrombosis with thrombocytopenia syndrome (tts)vaccine-induced prothrombotic immune thrombocytopenia (vipit)vitt covid-19

Identifiers

PMID36879697
PMCPMC9985429
OpenAlexW4318987675

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.